Abstract
Development of tolerance and dependence has been reported to occur upon chronic administration of traditional benzodiazepines (BZDs). We compared the effect of chronic treatment with abecarnil, a β-carboline derivative with high affinity for central BDZ receptors, and diazepam, the BDZ prototype, in mice.
After acute administration, abecarnil was as potent and effective as diazepam in protecting from bicuculline-induced convulsion. The time-course analysis of two peak equieffective doses of abecarnil (1.9 mg/kg p.o.) and diazepam (2.7 mg/kg p.o.) showed a similar duration of action. The anticonvulsant potency of diazepam was reduced in mice given chronic diazepam (25 mg/kg p.o., 2 times a day for 17 days). No tolerance to abecarnil was apparent when the drug was administered for the same period using a comparable dose (20 mg/kg p.o.). Severe symptoms of precipitated withdrawal were observed upon administration of the BDZ partial inverse agonist Ro 15-3505 in mice treated chronically with diazepam but not abecarnil. In mice made tolerant to diazepam, maximum [3H]-flumazenil binding sites were reduced in both cerebral cortex (−50%) and cerebellum (−55.2%). No changes in [3H]-flumazenil binding were measured in chronic abecarnil-treated mice.
These data indicate that abecarnil possesses a very low tolerance/dependence liability and does not affect BZD receptor density after chronic administration.
Similar content being viewed by others
References
Auta J, Giusti P, Guidotti A, Costa E (1994) Imidazenil, a partial positive allosteric modulator of GABAA receptor, exhibits low tolerance and dependence liabilities in the rat. J Pharmacol Exp Ther 270: 1262–1269
Ballenger JC, Mc Donald S, Noyes R, Rickels K, Sussman N, Woods S, Patin J, Singer J (1991) The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecamil (ZK 112–119) in generalized anxiety disorder. Phychopharmacol Bull 27: 171–179
Feely M, Boyland P, Picardo A, Cox A, Gent JP (1989) Lack of anticonvulsant tolerance with RU 32698 and Ro 17–1812. Eur J Pharmacol 164: 377–380
Finney DJ (1971) Probit analysis, 3rd Edition. Cambridge University Press, Cambridge, UK
Gallager DW, Marley RJ, Hernandez TD (1991) Biochemical and electrophysiological mechanisms underlying benzodiazepine tolerance and dependence. In: Pratt J (ed) The biological bases of drug tolerance and dependence. Academic Press, London, pp 49–70
Gobbi M, Barone D, Mennini T, Garattini S (1987). Diazepam and desmethyldiazepam differ in their affinity and efficacies at “central” and “peripheral” benzodiazepine receptors. J Pharm Pharmacol 39: 388–391
Grimm WE, Hershkovitz M (1981) The effect of chronic diazepam treatment on discrimination performance and [3H]-flunitrazepam binding in the brains of shocked and nonshocked rats. Psychopharmacology 74: 132–136
Haefely W, Martin JR, Schoch P. (1990) Novel anxiolytics that act as partial agonists at benzodiazepine receptors. Trends Pharmacol Sci 11:452–456
Haigh JRM, Feely M (1988). Tolerance to the anticonvulsant effect of benzodiazepines. Trends Pharmacol Sci 9: 361–365
Knoflach F, Drescher U, Schemer L, Malherbe P, Möhler H (1993) Full and partial agonism displayed by benzodiazepine receptor ligands at different recombinant GABAA receptor subtypes. J Pharmacol Exp Ther 266: 385–391
Krause W, Mengel H (1990) Pharmakokinetics of the anxiolytic β-carbolines derivative, abecarnil, in the mouse, the rat, the rabbit, the dog, the cynomologous monkey and the baboon. Studies on species differences. Drug Res 40: 522–529
Löscher W, Hönach D (1992) Withdrawal precipitation by benzodiazepine receptor antagonists in dog chronically treated with diazepam or the novel anxiolytic and anticonvulsant β-carboline abecarnil. Naunyn-Schmiedeberg's Arch Pharmacol 345: 452–460
Löscher W, Rundfeldt C (1990) Development of tolerance to clobazam in fully kindled rats: effects of intermittent flumazenil administration. Eur J Pharmacol 180: 255–271
Löscher W, Schwark WS (1985) Development of tolerance to the anticonvulsant effect of diazepam in amygadala kindled rats. Exp Neurol 90: 373–384
Löscher W, Hönach D, Scherkl R, Hashem A, Frey H-H (1990) Pharmacokinetics, anticonvulsant efficacy and adverse effects of the novel anxiolytic β-carboline abecarnil, a novel ligand for benzodiazepine receptors after acute and chronic administration in dogs. J Pharmacol Exp Ther 255: 541–548
Löscher W, Rundfeldt C, Hönach D (1991) Tolerance to anticonvulsant effect of the partial benzodiazepine-receptor agonist abecarnil in kindled rats involves learning. Eur J Pharmacol 202: 303–310
Martin JR, Pieri L, Bonetti EP, Schaffner R, Burkard WP, Cumin R, Haefely W (1988) Ro 16–6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor. Pharmacopsychiatry 21:360–369
Miller LG, Greenblatt DJ, Barnhill JG, Shader RI (1988) Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased-aminobutyricA receptor function. J Pharmacol Exp Ther 246: 170–176
Miller LG, Galpern WR, Greenblatt DJ, Lumpkin M, Shader RI (1990) Chronic benzodiazepine administration. VI. A partial agonist produces behavioral effects without tolerance or receptor alteration. J Pharmacol Exp Ther 254: 33–38
Moreau J-L, Jenck F, Pieri L, Schoch P, Martin JR, Haefely W (1990) Physical dependence induced in DBA/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16–6028. Eur J Pharmacol 190: 269–273
Pribilla I, Neuhaus R, Huba R, Hillmann M, Turner JD, Stephens DN, Schneider HH (1993) Abecamil is a full agonist at same, and a partial agonist at other recombinant GABAA receptor subtypes. In: Stephens DN (ed) Anxiolytic β-carbolines. From Molecolar Biology to the Clinic. Psychopharmacological Series 11. Springer, Heidelberg, pp 50–61
Primus RJ, Gallager DW (1992) GABAA receptor subunit niRNA levels are differentially influenced by chronic FG 7142 and diazepan exposure. Eur J Pharmacol 226: 21–28
Ritschel WA (1986) Handbook of basic pharmacokinetics. Drug Intelligence Publ, Hamilton, Ill, USA
Rosenberg HC, Chin TH (1981) Tolerance during chronic benzodiazepine treatment is associated with decreased receptor binding. Eur J Pharmacol 70: 453–460
Sacchi-Landriani G, Guardabasso V, Rocchetti M (1983) A microcomputer program for non-linear fitting. Comp Progr Biomed 16: 35–42
Sannerud CA, Ator NA, Griffiths RR (1992) Behavioral pharmacology of abecamil in baboons: self-injection, drug discrimination and physical dependence. Behav Pharmacol 3: 507–516
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51: 660–672
Scherkl R, Scheuler W, Frey H-H (1985) Anticonvulsant effect of clonazepam in dog: development of tolerance and physical dependence. Arch Int Pharmacodyn Ther 278: 249–260
Scherkl R, Schenler W, Frey H-H (1989) Clozepate in dogs: tolerance to the anticonvulsant effect and sign of physical dependence. Epilepsy Res 3: 144–150
Schneider HH, Turski L, Krause W, Stephens DN (1990) Short-and long-tern tolerance to abecarnil, a beta-carboline benzodiazepine-receptor ligand: antagonism of PTZ convulsion threshold vs. receptor occupation and plasma level in the mouse. Soc Neurosci Abstr 16: 1037
Serra M, Ghiani CA, Motzo C, Biggio G (1993) Pharmacological evidence for full agonist activity of abecarnil at certain GABAA receptors. In: Stephens DN (ed) Anxiolytic β-carbolines. From Molecular Biology to the Clinic. Psychopharmacological Series 11. Springer, Heidelberg, pp 62–78
Stephens DN, Schneider HH, Kerh W, Andrews JS, Retting K-J, Turski L, Schmiechen R, Turner JD, Jensen LH, Petersen EN, Honoré T, Bondo Hansen, J (1990) Abecarnil, a metabolically stable, anxioselective β-carboline acting at benzodiazepine receptors. J Pharmacol Exp Ther 253: 334–343
Stephens DN, Schneider HH, Turski L, Hillmann M, Huba R, Turner JD (1991) Abecamil: A β-carboline anxiolytic showing a selective action at central benzodiazepine receptors. Soc Neurosci Abstr 17: 1342
Steppuhn KG, Schneider HH, Turski L, Stephens DN (1993) Longterm treatment with abecarnil does not induce diazepam-like dependence in mice. J Pharmacol Exp Ther 264: 1395–1400
Tallman JF, Gallager, DW (1985) The GABAergic system: a locus of benzodiazepine action. Annu Rev Neurosci 8: 21–44
Tietz EI, Rosenberg HC, Chin TH (1986) Autoradiografic localization of benzodiazepine receptor down-regulation. J Pharmacol Exp Ther 236: 284–292
Turski L, Stephens DN, Jensen LH, Petersen EN, Meldrum BS, Patel S, Bondo Hansen J, Löscher W, Schneider HH, Schmiecben R (1990) Anticonvulsant action of the β-carboline abecarnil — Studies in rodents and baboon, Papio papio. J Pharmacol Exp Ther 253:344–352
Woods JH, Katz JL, Winger G (1987) Abuse liability of benzodiazepines. Pharmacol Rev 39: 251–419
Zanotti A, Mariot R, Contarino A, Lipartiti M, Giusti P (1996) Lack of anfconvulsant tolerance and benzodiazepine receptor down regulation with imidazenil in rats. Br J Pharmacol 117: 647–652
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Natolino, F., Zanotti, A., Contarino, A. et al. Abecarnil, a β-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice. Naunyn-Schmiedeberg's Arch Pharmacol 354, 612–617 (1996). https://doi.org/10.1007/BF00170836
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00170836